rs138914992
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001367561.1(DOCK7):c.3797G>A(p.Arg1266Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000702 in 1,608,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001367561.1 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 23Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001367561.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DOCK7 | NM_001367561.1 | MANE Select | c.3797G>A | p.Arg1266Gln | missense | Exon 31 of 50 | NP_001354490.1 | ||
| DOCK7 | NM_001330614.2 | c.3797G>A | p.Arg1266Gln | missense | Exon 31 of 50 | NP_001317543.1 | |||
| DOCK7 | NM_001271999.2 | c.3797G>A | p.Arg1266Gln | missense | Exon 31 of 49 | NP_001258928.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DOCK7 | ENST00000635253.2 | TSL:5 MANE Select | c.3797G>A | p.Arg1266Gln | missense | Exon 31 of 50 | ENSP00000489124.1 | ||
| DOCK7 | ENST00000454575.6 | TSL:1 | c.3797G>A | p.Arg1266Gln | missense | Exon 31 of 49 | ENSP00000413583.2 | ||
| DOCK7 | ENST00000251157.10 | TSL:5 | c.3797G>A | p.Arg1266Gln | missense | Exon 31 of 50 | ENSP00000251157.6 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152010Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000850 AC: 21AN: 247044 AF XY: 0.0000825 show subpopulations
GnomAD4 exome AF: 0.0000583 AC: 85AN: 1456832Hom.: 0 Cov.: 30 AF XY: 0.0000483 AC XY: 35AN XY: 724358 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000184 AC: 28AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74366 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 23 Uncertain:3
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1266 of the DOCK7 protein (p.Arg1266Gln). This variant is present in population databases (rs138914992, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with DOCK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 582642). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DOCK7 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not provided Uncertain:2
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Inborn genetic diseases Uncertain:1
The c.3704G>A (p.R1235Q) alteration is located in exon 30 (coding exon 30) of the DOCK7 gene. This alteration results from a G to A substitution at nucleotide position 3704, causing the arginine (R) at amino acid position 1235 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at